Fujiwara Y - Search Results

1

Risk factors for pneumonitis in patients with non-small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy: A retrospective analysis.

Yamaguchi T, Shimizu J, Oya Y, Watanabe N, Hasegawa T, Horio Y, Inaba Y, Fujiwara Y. Yamaguchi T, et al. Among authors: fujiwara y. Thorac Cancer. 2022 Mar;13(5):724-731. doi: 10.1111/1759-7714.14308. Epub 2022 Jan 19. Thorac Cancer. 2022. PMID: 35044093 Free PMC article.

2

High sensitivity detection of epidermal growth factor receptor mutations in the pleural effusion of non-small cell lung cancer patients.

Kimura H, Fujiwara Y, Sone T, Kunitoh H, Tamura T, Kasahara K, Nishio K. Kimura H, et al. Among authors: fujiwara y. Cancer Sci. 2006 Jul;97(7):642-8. doi: 10.1111/j.1349-7006.2006.00216.x. Cancer Sci. 2006. PMID: 16827805 Free PMC article.

3

Serum total bilirubin as a predictive factor for severe neutropenia in lung cancer patients treated with cisplatin and irinotecan.

Fujiwara Y, Sekine I, Ohe Y, Kunitoh H, Yamamoto N, Nokihara H, Simmyo Y, Fukui T, Yamada K, Tamura T. Fujiwara Y, et al. Jpn J Clin Oncol. 2007 May;37(5):358-64. doi: 10.1093/jjco/hym033. Epub 2007 May 30. Jpn J Clin Oncol. 2007. PMID: 17538190

4

Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxel.

Kawaishi M, Fujiwara Y, Fukui T, Kato T, Yamada K, Ohe Y, Kunitoh H, Sekine I, Yamamoto N, Nokihara H, Watabe T, Shimoda Y, Arao T, Nishio K, Tamura T, Koizumi F. Kawaishi M, et al. Among authors: fujiwara y. J Thorac Oncol. 2009 Feb;4(2):208-13. doi: 10.1097/JTO.0b013e318193030d. J Thorac Oncol. 2009. PMID: 19179898 Free article.

5

Secondary osteosarcoma developing 10 years after chemoradiotherapy for non-small-cell lung cancer.

Yagishita S, Horinouchi H, Yorozu T, Kitazono S, Mizugaki H, Kanda S, Fujiwara Y, Nokihara H, Yamamoto N, Mori T, Tsuta K, Sumi M, Tamura T. Yagishita S, et al. Among authors: fujiwara y. Jpn J Clin Oncol. 2014 Feb;44(2):191-4. doi: 10.1093/jjco/hyt192. Epub 2013 Dec 13. Jpn J Clin Oncol. 2014. PMID: 24338556

6

Clinicopathological features in young patients treated for small-cell lung cancer: significance of immunohistological and molecular analyses.

Taniyama TK, Nokihara H, Tsuta K, Horinouchi H, Kanda S, Fujiwara Y, Yamamoto N, Koizumi F, Yunokawa M, Tamura T. Taniyama TK, et al. Among authors: fujiwara y. Clin Lung Cancer. 2014 May;15(3):244-7. doi: 10.1016/j.cllc.2013.06.012. Epub 2013 Dec 14. Clin Lung Cancer. 2014. PMID: 24456892

7

Adjuvant chemotherapy in patients with completely resected small cell lung cancer: a retrospective analysis of 26 consecutive cases.

Mizugaki H, Fujiwara Y, Yamamoto N, Yagishita S, Kitazono S, Tanaka A, Horinouchi H, Kanda S, Nokihara H, Tsuta K, Asamura H, Tamura T. Mizugaki H, et al. Among authors: fujiwara y. Jpn J Clin Oncol. 2014 Sep;44(9):835-40. doi: 10.1093/jjco/hyu092. Epub 2014 Aug 5. Jpn J Clin Oncol. 2014. PMID: 25097183

8

Epidermal growth factor receptor mutation is associated with longer local control after definitive chemoradiotherapy in patients with stage III nonsquamous non-small-cell lung cancer.

Yagishita S, Horinouchi H, Katsui Taniyama T, Nakamichi S, Kitazono S, Mizugaki H, Kanda S, Fujiwara Y, Nokihara H, Yamamoto N, Sumi M, Shiraishi K, Kohno T, Furuta K, Tsuta K, Tamura T. Yagishita S, et al. Among authors: fujiwara y. Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):140-8. doi: 10.1016/j.ijrobp.2014.08.344. Epub 2014 Oct 13. Int J Radiat Oncol Biol Phys. 2015. PMID: 25442336

9

Phase I study of ipilimumab in phased combination with paclitaxel and carboplatin in Japanese patients with non-small-cell lung cancer.

Horinouchi H, Yamamoto N, Fujiwara Y, Sekine I, Nokihara H, Kubota K, Kanda S, Yagishita S, Wakui H, Kitazono S, Mizugaki H, Tokudome T, Tamura T. Horinouchi H, et al. Among authors: fujiwara y. Invest New Drugs. 2015 Aug;33(4):881-9. doi: 10.1007/s10637-015-0243-5. Epub 2015 May 1. Invest New Drugs. 2015. PMID: 25924991 Free PMC article. Clinical Trial.

10

Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non--Small-Cell Lung Cancer.

Kitazono S, Fujiwara Y, Tsuta K, Utsumi H, Kanda S, Horinouchi H, Nokihara H, Yamamoto N, Sasada S, Watanabe S, Asamura H, Tamura T, Ohe Y. Kitazono S, et al. Among authors: fujiwara y. Clin Lung Cancer. 2015 Sep;16(5):385-90. doi: 10.1016/j.cllc.2015.03.008. Epub 2015 Apr 4. Clin Lung Cancer. 2015. PMID: 25937270

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,244 results

Search Page

Filters